Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Sperm cryopreservation is an essential procedure for male fertility in certain situations, like cancer, vasectomy or other obstructive surgeries, autoimmunity diseases, immunosuppressive therapeutic strategies, or when the male partner is incapable of providing sufficient spermatozoa on the day of egg retrieval. Semen cryopreservation is mainly associated with decreased viability, motility, and DNA damage of spermatozoa due to the osmotic and mechanical stresses attributed to the freezing-thaw- ing process. Sperm cryodamage mainly originates from osmotic changes, cold shock, intracellular ice crystal formation, and oxidative stress. Based on this, some protective strategies have been proposed and developed, even the addition of cryoprotectants. Recently, Platelet-rich plasma (PRP) is becoming very popular in medicine. The therapeutic effect of platelets is related to alpha granule contents. A study showed that PRP modulates ROS toxicity through a different mechanism. VEGF detoxify oxidative damage via activation of the nuclear factor (erythroid- derived 2)-like2 (Nrf2) pathway. Oxidative stress modulation and apoptosis inhibition both have an essential role during the cryopreservation process. In this case, it raises the question of whether PRP can improve the sperm quality against freeze-thawing-induced damage. Therefore, the present study aimed to examine different concentrations of PRP on frozen-thawed sperm parameters of vitality, morphology, motility and DNA fragmentation
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| experimental: semen | Experimental | a semen of normal semen analysis |
|
| placebo: semen | Experimental | a semen of normal semen analysis |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| autologous platelet-rich plasma supplement | Biological | the semen of the additional autologous platelet-rich plasma supplement group will be added by 5% PRP and mixed with Sperm Freezing Medium and undergo cryopreservation by Sperm vitrification for 14 days |
| Measure | Description | Time Frame |
|---|---|---|
| Sperm vitality | Sperm vitality (percentage) after thawing | 14 days after cryopreservation |
| Measure | Description | Time Frame |
|---|---|---|
| Sperm motility | Sperm motility (percentage) after thawing | 14 days after cryopreservation |
| Sperm morphology | Sperm morphology (percentage of normal form) after thawing |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Choermin Thitipatlertdech, M.D. | Contact | +6692-2659265 | choermin@hotmail.com | |
| Nisanart Booning, M.D. | Contact | +6684-1653945 | tobee_b@hotmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rajavithi hospital | Recruiting | Bangkok | 10400 | Thailand |
drafting official document and distribute to IPD about study protocal, statistical analysis plan. inform consent and clinical study report
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| no autologous platelet-rich plasma supplement | Biological | the semen mixed with Sperm Freezing Medium and undergo cryopreservation by Sperm vitrification for 14 days |
|
| 14 days after cryopreservation |
| DNA fragmentation | DNA fragmentation (percentage) after thawing | 14 days after cryopreservation |